See also this year's filing and all EDGAR filings for this company.
PDF Report 0001745020_2023_Theseus_Pharmaceuticals_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001745020, Theseus Pharmaceuticals Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 0 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 416,000 |
| 3 | remainder_Assets | 222,031,000 |
| 4 | LiabilitiesCurrent | 11,130,000 |
| 5 | LiabilitiesNoncurrent | 3,236,000 |
| 6 | remainder_Liabilities | 466,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 18,388,000 |
| 9 | ResearchAndDevelopmentExpense | 35,698,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 3,478,000 |
| 13 | remainder_ComprehensiveNetIncome | -386,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 222,447,000 |
| 1 | Liabilities | 14,832,000 |
| 2 | Expenses | 54,086,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 207,615,000 |
| 5 | NetIncome | -50,608,000 |
| 6 | ComprehensiveNetIncome | -50,801,000 |
| 7 | BaseVar | 147,614,500 |
| 8 | EconomicCapitalRatio | 2.58 |